Pharmaceutical

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company")…

11 months ago

Onco-Innovations’ Licensed Technology Shown in Study to Successfully Prevent Regeneration of Cancer Cells

VANCOUVER, BC / ACCESS Newswire / January 16, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased…

11 months ago

Introducing BenCura University

KENNESAW, GA / ACCESS Newswire / January 16, 2025 / At BenCura, continuous education and quality improvement form the cornerstone…

11 months ago

Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - January 16, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics…

11 months ago

Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma

Strategic hire underscores Emmes Group's growth and commitment to biopharma market ROCKVILLE, Md., Jan. 16, 2025 /PRNewswire/ -- Emmes Group®,…

11 months ago

Rapid Dose Completes Issuance of Shares as Payment of Directors’ Fees

Burlington, Ontario--(Newsfile Corp. - January 16, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to…

11 months ago

ModMed Named Leader in Physician Practice EHR Software for 11 Specialties in 2025 Black Book Awards

TAMPA, FLORIDA / ACCESS Newswire / January 16, 2025 / ModMed continues to dominate the field of physician practice electronic…

11 months ago

Veos Pharmaceuticals Launches ThymoTropin™ to Support Muscle Health and Preservation on Weight Loss and Aging Journeys

Clinically Proven Myostatin-Targeting Formula to Enhance Muscle Growth, Repair, and Endurance MADRID, SPAIN / ACCESS Newswire / January 16, 2025…

11 months ago

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency…

11 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) --…

11 months ago